Sage Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsSage Therapeutics

Sage Therapeutics(SAGE)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Apomorphine	Apomorphine	2022-02-23	2023-2036	Parkinson disease , Erectile dysfunction
Chlorhexidine	Chlorhexidine	2005-04-25	2024-2027	Periodontal diseases , Infectious skin diseases , Gram-negative bacterial infections , Oral candidiasis , Gram-positive bacterial infections , Hypercholesterolemia , Coronary artery disease , Hypertriglyceridemia , Hyperlipoproteinemias
Zulresso	Brexanolone	2019-06-17	2029-2037	Postpartum depression

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

psychotic disorders

,

mental disorders

,

,

essential tremor

,

,

alcohol drinking

,

,

respiratory distress syndrome

,

acute lung injury

,

newborn respiratory distress syndrome

,

,

post-traumatic stress disorders

,

postpartum depression

,

,

depressive disorder

,

traumatic stress disorders

,

attention deficit disorder with hyperactivity

Chlorhexidine gluconate

,

peri-implantitis

,

periodontal diseases

,

,

peri-implantitis

,

periodontal diseases

,

,

rheumatoid arthritis

,

,

,

,

,

ocular hypertension

,

,

open-angle glaucoma

Cetylpyridinium chloride

,

healthy volunteers/patients

muscular atrophy

,

spinal muscular atrophy

,

,

myocardial infarction

,

wounds and injuries

,

,

,

,

coronary occlusion

,

ventricular tachycardia

,

,

,

lice infestations

,

,

parasitic diseases

,

mite infestations

,

healthy volunteers/patients

,

,

respiratory distress syndrome

,

acute lung injury

,

newborn respiratory distress syndrome

,

Antineoplaston a10

fecal incontinence

,

,

,

,

thrombocytopenic purpura idiopathic

,

,

photosensitivity disorders

,

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

multiple myeloma

,

plasma cell neoplasms

,

rheumatoid arthritis

,

,

,

chronic hepatitis c

,

chronic hepatitis b

,

,

chronic hepatitis

,

,

,

anxiety disorders

,

,

,

,

,

,

acquired immunodeficiency syndrome

,

communicable diseases

,

,

immunologic deficiency syndromes

,

inflammatory breast neoplasms

,

atrial fibrillation

,

macular degeneration

,

,

pulmonary tuberculosis

,

,

,

thrombocytopenia

,

non-small-cell lung carcinoma

,

,

systemic lupus erythematosus

,

,

,

,

diabetes mellitus

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

atherosclerosis

,

ovarian neoplasms

,

endometrial neoplasms

,

ovarian epithelial carcinoma

,

respiratory syncytial viruses

,

breast neoplasms

,

,

postmenopausal osteoporosis

,

alzheimer disease

,

,

personal satisfaction

,

hypersensitivity

,

dentin sensitivity

,

tension-type headache

,

,

,

prostatic hyperplasia

,

,

,

,

,

,

,

spinal cord injuries

,

erectile dysfunction

,

,

chronic obstructive pulmonary disease

,

,

migraine disorders

,

type 2 diabetes mellitus

,

,

prostatic neoplasms

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use